osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'aura ,(-laura)']
adaura update. still striking, however waning dfs benefits were presented by dr. tsuboi. step by step, the issues are becoming clearer, yet many questions remain unanswered. the ultimate answer may well be found in the dialogue with our patients. #lcsm #esmo22 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC